Assignee
GENSUN BIOPHARMA INC
US·17 granted patents·7 pending applications·22 citations·filing 2017–2025
Top patents by PatentIndex Score
24 records- 0192US10537637B2Checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2017·Granted Jan 21, 2020·5 cites·8 claims
- 0291US11518813B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2020·Granted Dec 6, 2022·2 cites·14 claims
- 0391US10851157B2Antagonists targeting the TGF-β pathwayGENSUN BIOPHARMA INC·Filed 2019·Granted Dec 1, 2020·5 cites·34 claims
- 0491US10647773B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted May 12, 2020·4 cites·15 claims
- 0591US2025361306A1Antitumor immune checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0689US11001635B2Antitumor antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted May 11, 2021·2 cites·4 claims
- 0788US11976133B2Bispecific T cell engagersGENSUN BIOPHARMA INC·Filed 2021·Granted May 7, 2024·2 cites·10 claims
- 0887US12404336B2Bispecific antagonist comprising a LAG-3 binding domainGENSUN BIOPHARMA INC·Filed 2023·Granted Sep 2, 2025·0 cites·20 claims
- 0986US11517623B2Anti-PD-1 antibodies, antigen-binding portions thereof and checkpoint regulator antogonists comprising the sameGENSUN BIOPHARMA INC·Filed 2019·Granted Dec 6, 2022·1 cites·17 claims
- 1082US12350333B2Checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2022·Granted Jul 8, 2025·0 cites·16 claims
- 1181US2026055206A1Bispecific t cell engagersGENSUN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1280US12570765B2Trispecific T cell engagersGENSUN BIOPHARMA INC·Filed 2024·Granted Mar 10, 2026·0 cites·5 claims
- 1379US2026014253A1Checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1478US11945873B2Antitumor antagonistsGENSUN BIOPHARMA INC·Filed 2021·Granted Apr 2, 2024·0 cites·6 claims
- 1578US10894823B2Trispecific inhibitors for cancer treatmentGENSUN BIOPHARMA INC·Filed 2017·Granted Jan 19, 2021·1 cites·7 claims
- 1675US11851493B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2020·Granted Dec 26, 2023·0 cites·20 claims
- 1774US11667716B2Bispecific antagonist comprising a LAG-3 binding domainGENSUN BIOPHARMA INC·Filed 2020·Granted Jun 6, 2023·0 cites·19 claims
- 1870US10597453B2Antitumor immune checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 1967US12018073B2Antagonists targeting the TGF-β pathwayGENSUN BIOPHARMA INC·Filed 2020·Granted Jun 25, 2024·0 cites·22 claims
- 2064US2025388703A1Multi-specific molecules and mentod of use and making thereofGENSUN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2160US2021115123A1Trispecific inhibitors for cancer treatmentGENSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2258US12060434B2Trispecific T cell engagersGENSUN BIOPHARMA INC·Filed 2021·Granted Aug 13, 2024·0 cites·4 claims
- 2358US2022389120A1Multispecific antagonistsGENSUN BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2456US2024279324A1Multispecific antagonistsGENSUN BIOPHARMA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENSUN BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →